Avita Medical
RCEL
80 hedge funds and large institutions have $129M invested in Avita Medical in 2023 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 17 closing their positions.
57% more capital invested
Capital invested by funds: $82.5M → $129M (+$47M)
56% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 16
53% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 17
13% more funds holding
Funds holding: 71 → 80 (+9)
10% more call options, than puts
Call options by funds: $1.1M | Put options by funds: $1M
6.75% more ownership
Funds ownership: 23.3% → 30.05% (+6.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$17.4M |
| 2 |
State Street
Boston,
Massachusetts
|
+$5.35M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.3M |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$3.16M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$5.47M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.2M |
| 3 |
Jane Street
New York
|
-$1.97M |
| 4 |
Renaissance Technologies
New York
|
-$1.65M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.53M |
RCEL Hedge Fund Activity: Q2 2023 in Review
80 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2023, worth a combined $129M — up 57% from $82.5M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new RCEL positions and 17 closed out — a net gain of 9 holders — while 25 added to existing stakes and 16 trimmed.
The largest buyer was BlackRock, adding an estimated $17.4M. The largest seller was Pura Vida Investments, cutting an estimated $5.47M.
- 80 institutional investors held Avita Medical (RCEL) as of Q2 2023, up from 71 in Q1 2023.
- Funds reported $129M of Avita Medical stock for Q2 2023, up 57% quarter-over-quarter.
- 26 funds opened new Avita Medical positions in Q2 2023 and 17 closed out, a net change of +9 holders.
- The largest Avita Medical buyer in Q2 2023 was BlackRock, an estimated $17.4M added.
- The largest Avita Medical seller in Q2 2023 was Pura Vida Investments, an estimated $5.47M sold.
Based on aggregated 13F filings for Q2 2023.